mercredi 27 septembre 2017

Onco Actu du 27 septembre 2017

2. Etiologie

No evidence for genetic link between height and testicular cancer [Institute of Cancer Research]

4.1 Dép., diag. & prono. - Prostate

A prostate ‘Pep Talk’ is the wrong way to get men thinking about cancer screening [HealthNewsReview]

4.5 Dép., diag. & prono. - Colorectal

Low-Tech Outreach Methods Improve Colorectal Cancer Screening [NCI]

4.9 Dép., diag. & prono. - Sein

NCI-funded TMIST study compares 2-D and 3-D mammography for finding breast cancers [NCI]

5. Traitements

Pelvis-targeting radiotherapy safe for prostate cancer patients [Cancer Research UK]

5.12.2 Immunothérapies - CAR-T

British biotech joins race to find 'living medicines' for cancer after cash injection [The Telegraph]

Next-gen CAR-T, TCR player Autolus gains $80M for clinical trial work [EndPoints]

5.3 Traitements - FDA, EMA, NICE...

EMA Warns of Major Staff Losses in HQ Relocation [RAPS]

Update on EMA relocation preparedness [EMA]

6. Lutte contre les cancers

Devastation to Puerto Rico threatens global medicine supply [Pharmafile]

Mesothelioma Awareness Day: How research is tackling the deadly legacy of asbestos [Cancer Research UK]

6.10.1 Politiques (USA)

Senate panel blocks NIH from revising translational research awards [Science]

6.11 Patients

Taking part in clinical trials – Tommy’s story [Cancer Research UK]

6.6 Publications

Steps towards transparency in research publishing [Nature]

6.7 DMP, Big Data & applis

The drug-maker's guide to the galaxy [Nature]

6.7.2 Applis

Apple, Verily and J&J Among 9 Selected for FDA Digital Health Pilot [RAPS]

FDA selects participants for new digital health software precertification pilot program [FDA]

6.8 Communication

You’ve heard about precision medicine. Now get ready for precision drug ads [STAT]

6.9 Controverses

Award or Reward? Which comes first, NIH funding or research impact? [BioRxiv]